Itau Unibanco Holding S.A.
TEVA icon

Itau Unibanco Holding S.A.’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-27,000
Closed -$453K – 441
2025
Q2 		$453K Buy
+27,000
New +$436K 0.02% 157
2019
Q4 		– Sell
-11,405
Closed -$105K – 973
2019
Q3 		$105K Hold
11,405
– – 0.01% 206
2019
Q2 		$105K Sell
11,405
-6,641
-37% -$80.1K 0.01% 532
2019
Q1 		$274K Hold
18,046
– – 0.01% 161
2018
Q4 		$274K Buy
18,046
+38
+0.2% +$779 0.01% 161
2018
Q3 		$388K Buy
18,008
+7,167
+66% +$166K 0.02% 147
2018
Q2 		$263K Sell
10,841
-586
-5% -$11.9K 0.03% 230
2018
Q1 		$195K Buy
11,427
+7,531
+193% +$147K ﹤0.01% 381
2017
Q4 		$74K Buy
3,896
+1,231
+46% +$18.5K ﹤0.01% 394
2017
Q3 		$149K Buy
2,665
+653
+32% +$14.7K 0.01% 484
2017
Q2 		$67K Buy
2,012
+1,813
+911% +$56.1K 0.01% 265
2017
Q1 		$6K Buy
+199
New +$6.79K ﹤0.01% 624

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Phoenix Financial
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
Menora Mivtachim Holdings
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
Harel Insurance Investments & Financial Services
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
Migdal Insurance & Financial Holdings
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Clal Insurance
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
Lingotto Investment Management
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
Rubric Capital Management (New York)
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PointState Capital
PointState Capital New York $7.82B AUM 43.51% 1-Year Est. Return

Itau Unibanco Holding S.A.'s TEVA Position: Q3 2025 in Review

Itau Unibanco Holding S.A. sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2025, closing a stake of 27,000 shares — an estimated $453K sold.

Itau Unibanco Holding S.A. first reported a position in TEVA in Q1 2017 and held it in 12 quarters. The position peaked at $453K in Q2 2025. 553 funds tracked by Wall St. Rank hold TEVA as of Q3 2025.

  • Itau Unibanco Holding S.A. reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2025 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 27,000 Teva Pharmaceutical Industries Limited shares in Q3 2025, an estimated $453K.
  • Itau Unibanco Holding S.A. first reported a position in Teva Pharmaceutical Industries Limited in Q1 2017 and held it in 12 quarters.
  • Itau Unibanco Holding S.A.'s Teva Pharmaceutical Industries Limited position peaked at $453K in Q2 2025.
  • 553 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2025.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q3 2025, filed 12 Nov 2025.